Skip to main content

Animations

MJFF Publications

1811 - 1820 of 8818 Results
Title
Year
  • Year
  • 2020
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • Summary Details
    OPEN
    Title: Editorial: Protein Degradation Pathways in Parkinson's Disease and Neurodegeneration
    Journal Name: Frontiers in Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnins.2020.00741
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Disclosure of individual research results at federally funded Alzheimer's Disease Research Centers
    Journal Name: Alzheimer's & Dementia: Translational Research & Clinical Interventions
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/trc2.12213
    Citation Count: 25
  • Summary Details
    OPEN
    Title: Auditory and olfactory findings in patients with USH2A‐related retinal degeneration—Findings at baseline from the rate of progression in USH2A‐related retinal degeneration natural history study (RUSH2A)
    Journal Name: American Journal of Medical Genetics Part A
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/ajmg.a.62437
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Meaning and purpose in Huntington’s disease: a longitudinal study of its impact on quality of life
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/acn3.51424
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Multi‐cohort profiling reveals elevated CSF levels of brain‐enriched proteins in Alzheimer’s disease
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/acn3.51402
    Citation Count: 48
  • Summary Details
    OPEN
    Title: Neurofilament light chain is a cerebrospinal fluid biomarker in hereditary spastic paraplegia
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/acn3.51358
    Citation Count: 16
  • Summary Details
    OPEN
    Title: α4β2 * Nicotinic Cholinergic Receptor Target Engagement in Parkinson Disease Gait–Balance Disorders
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/ana.26102
    Citation Count: 23
  • Summary Details
    OPEN
    Title: Speech Biomarkers in Rapid Eye Movement Sleep Behavior Disorder and Parkinson Disease
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/ana.26085
    Citation Count: 109
  • Summary Details
    OPEN
    Title: Alpha‐Synuclein Oligomers and Neurofilament Light Chain Predict Phenoconversion of Pure Autonomic Failure
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/ana.26089
    Citation Count: 77
  • Summary Details
    OPEN
    Title: Pharmacogenetic Predictors of Cannabidiol Response and Tolerability in Treatment‐Resistant Epilepsy
    Journal Name: Clinical Pharmacology & Therapeutics
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/cpt.2408
    Citation Count: 31
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.